Patients undergoing resection of Merkel cell carcinoma have improved distant metastasis-free survival with adjuvant pembrolizumab — but any benefits for overall survival remain to be seen.
Understanding the stages of Merkel cell carcinoma (MCC) helps you and your physician know how far the cancer has grown or spread. These stages also guide decisions about the treatment options your ...
We unite the leading researchers and cancer specialists of Fred Hutch and UW Medicine so you can take part in Merkel cell carcinoma (MCC) research through clinical trials not available everywhere.
Please provide your email address to receive an email when new articles are posted on . Merkel cell carcinoma is often diagnosed after metastasis to other organs. However, new findings show those with ...
"Parrotheads" and casual fans of Caribbean living mourned the death of "Margaritaville" singer Jimmy Buffett over the weekend, who died at the age of 76 after a years-long battle with a rare and ...
In a prospective study of patients with stages I-III Merkel cell carcinoma (MCC), seropositivity for rising polyomavirus oncoprotein antibody titers conferred a 58% risk for recurrence at 12 months, ...
Recurrence-free survival was numerically higher with adjuvant pembrolizumab, but difference was not significant. HealthDay News — For patients with resected Merkel cell carcinoma (MCC), adjuvant ...
Please provide your email address to receive an email when new articles are posted on . The 5-year survival rate of patients with Merkel cell carcinoma was higher in Medicaid expansion vs.
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
225Ac-SSO110 has received U.S. FDA Orphan Drug Designation Initial safety data from SANTANA-225 in ES-SCLC and MCC expected in 2026 Potential to address a broad range of neuroendocrine cancers BERLIN, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results